Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep > NAM working with the World Hepatitis Alliance and the European Liver Patients Association www.nam.org.uk www.worldhepatitisalliance.org www.elpa-info.org Rohit Loomba at the 2018 AASLD Liver Meeting. Photo by Liz Highleyman.The Liver Meeting: NAFLDThyroid hormone receptor agonists reduce liver fat in people with NAFLD. News from The Liver Meeting 2018Read our 2018 Liver Meeting news bulletin. Masatoshi Kudo, Kindai University, Osaka, presenting at the AASLD Liver Meeting 2018. Photo by Liz Highleyman. The Liver Meeting: Hepatocellular carcinomaNivolumab works well for liver cancer patients with advanced disease. Alina Allen at The Liver Meeting 2018. Photo by Liz Highleyman.The Liver Meeting: NAFLD and cancerPeople with fatty liver disease are at greater risk for multiple cancers. Kathleen Schwarz at The Liver Meeting 2018. Photo by Liz Highleyman.The Liver Meeting: Treatment outcomesSofosbuvir/ledipasvir cures most young children with hepatitis C. New to hepatitis?Read our introductory information on viral hepatitis > infohep news Hepatitis C elimination Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... NAFLD Burden of severe liver disease due to fatty liver will more than double by 2030 Keith Alcorn / 07 December 2018 If current trends in obesity and diabetes continue, at least 520 million people will be living with non-alcoholic fatty liver disease in western Europe, China, Japan and the United States by 2030, ... NAFLD Thyroid hormone receptor agonists reduce liver fat in people with NAFLD Liz Highleyman / 29 November 2018 Thyroid hormone activation appears to be a promising approach for treating fatty liver disease, according to a pair of studies presented at the AASLD Liver Meeting this month in San Francisco. Two thyroid ... Hepatocellular carcinoma (HCC) Nivolumab works well for liver cancer patients with advanced disease Liz Highleyman / 26 November 2018 Nivolumab (Opdivo), a checkpoint inhibitor that helps the immune system fight cancer, was associated with tumour shrinkage or disease stabilisation in just over half of hepatocellular carcinoma (HCC) patients with substantial liver function ... Hepatitis C elimination Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs Michael Carter / 26 November 2018 Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. ... View all infohep news Editors' picks from other sources Rwanda launches 5-year campaign to eradicate hepatitis C Xinhua / 12 December 2018 Moving on with my life: Getting cured of hepatitis C YouTube / 07 December 2018 Bulgarian Harm Reduction Drown in Bureaucracy: Interview with Yuliya Georgieva Drug Reporter / 07 December 2018 The silent epidemic killing more people than HIV, malaria or TB Nature / 07 December 2018 Millions flock to free tests as Egypt seeks to eradicate hepatitis C Reuters / 06 December 2018 Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug MSF / 05 December 2018 8 Lessons Learned at the European Harm Reduction Conference Drug Reporter / 04 December 2018 Perinatal Exposure to HCV Leads to Earlier Cirrhosis AJMC / 03 December 2018 Egypt's health minister launches second phase of '100 million healthy lives' campaign Ahram / 03 December 2018 This City’s Overdose Deaths Have Plunged. Can Others Learn From It? New York Times / 26 November 2018 View all news from other sources Latest library resources Safer heroin injecting TypeWeb page Published2013 AuthorJon Derricott A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page CountryRussian Federation, Turkey, Western and Central Europe Published2013 AuthorLiver International Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 TypeWeb page CountryUnited States PublishedApril 2013 AuthorAmerican Association for the Study of Liver Diseases View all resources Looking for country specific news, resources and services?Visit our country information pages > Keep up to date with the latest hepatitis newsSign up for our free monthly email bulletin >